Summit Securities Group’s Harvard Bioscience HBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-310
Closed -$1K 578
2024
Q2
$1K Buy
+310
New +$1K ﹤0.01% 417